Drawing for CELLFLEX

USPTO serial 79200325

CELLFLEX

Reviewed by CopyMark Law Group

Reg. 5319494Status 707Renewal
Filing date
Status date
Registration date
Oct 31, 2017
Examiner
EINSTEIN, MATTHEW T
Law office
Historical data usage

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Need help with CELLFLEX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer Sheehan Anderson

Jennifer Sheehan Anderson Bridge Intellectual Property Services PLLC143 CadyCenter, Ste. 209Northville, MI 48167United States

Goods and services

ClassDescriptionStatusFirst use
005[ Medicines for intravenous therapy for the treatment of dialysis, hemodialysis, automatic apheresis and for vesical irrigation; sterile solutions, namely, sterilizing preparations for human or veterinary medical use packaged in flexible bags; pharmaceutical, medical, hospital and veterinary, medical products for intravenous injection, namely, pharmaceutical preparations for dialysis, hemodialysis, automatic apheresis and for vesical irrigation; medical products packaged in flexible bags, namely, ophthalmic solutions, solutions for dialysis and hemodialysis for automatic apheresis, solutions for vesical irrigation, solutions for irrigation in urology and arthroscopy, freezing and thawing solutions for erythrocytes, washing solutions for erythrocytes and cells ]SECTION 71 - CANCELLED—
010Articles for medical use, namely, flexible vessels for human and veterinary medical use in the nature of blood containers for medical purposes, intravenous feeding bottles, intravenous bags sold empty for intravenous therapy; flexible vessels for collecting and preserving biological culture media, namely, blood collection bags for medical and veterinary purposes; medical products for perfusion, namely, tubes and tubing, connectors, caps, tips, nozzles, spike ports; medical products, namely, bags for perfusion; flexible bags and vessels, namely, blood collection bags for medical and veterinary purposes for collecting and preserving stem cells, blood and blood derivatives such as blood plasma; bags and vessels for collecting and preserving biological culture media for laboratories namely, blood collection bags for medical and veterinary purposes; medical blood treatment apparatus; parts and accessories for the aforesaid products, namely, tubing sets, tubes, containers, packaging and disposable materials for medical and pharmaceutical use; packaging of injectable medical solutions, namely, injection device for pharmaceuticals; medical devices and connectors used for perfusion, blood transfusions, cell therapy, namely, cryopreservation of stem cellsACTIVE—
020[ Industrial flexible packaging of plastic for pharmaceutical products for intravenous injection, namely, flexible containers of plastics for the primary packaging and storage of liquids for commercial or industrial use ]SECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 23, 2026RNWLINTERNATIONAL REGISTRATION RENEWED—
Jul 2, 2026INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
May 26, 2026INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
May 26, 2026INPCINVALIDATION PROCESSED—
Nov 5, 2025INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Mar 5, 2025NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Mar 5, 202571.PREGISTERED - PARTIAL SEC 71 ACCEPTED—
Feb 21, 2025EROPTEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED—
Aug 23, 2024PR71POST REGISTRATION ACTION MAILED - SEC.71—
Jul 15, 2024APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 31, 2023ES71TEAS SECTION 71 RECEIVED—
Nov 4, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Oct 31, 2022REM3COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED—
Aug 25, 2020NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 13, 2018FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Feb 8, 2018FICSFINAL DISPOSITION NOTICE SENT TO IB—
Feb 8, 2018FIMPFINAL DISPOSITION PROCESSED—
Jan 31, 2018FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Oct 31, 2017R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Aug 18, 2017GPNXNOTIFICATION PROCESSED BY IB—
Aug 15, 2017NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Aug 15, 2017PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 2, 2017OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Aug 2, 2017OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Jul 26, 2017NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jul 11, 2017CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jul 10, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 10, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 10, 2017ERFRTEAS REQUEST FOR RECONSIDERATION RECEIVED—
Apr 21, 2017GNFNNOTIFICATION OF FINAL REFUSAL EMAILED—
Apr 21, 2017GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 21, 2017CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Mar 31, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Mar 31, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Mar 31, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 3, 2017RFNTREFUSAL PROCESSED BY IB—
Jan 21, 2017MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 19, 2017RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jan 19, 2017RFRRREFUSAL PROCESSED BY MPU—
Jan 19, 2017RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jan 18, 2017CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 17, 2017DOCKASSIGNED TO EXAMINER—
Jan 17, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 12, 2017REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance